Cancer Cell International,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 22, 2024
Abstract
Cancer
remains
a
major
global
health
challenge,
with
the
persistence
of
cancer
stem
cells
(CSCs)
contributing
to
treatment
resistance
and
relapse.
Despite
advancements
in
therapy,
targeting
CSCs
presents
significant
hurdle.
Non-thermal
gas
plasma,
also
known
as
CAP,
represents
an
innovative
treatment.
It
has
recently
gained
attention
for
its
often
found
be
selective,
immunogenic,
potent
anti-cancer
properties.
CAP
is
composed
collection
transient,
high-energy,
physically
chemically
active
entities,
such
reactive
oxygen
species
(ROS).
acknowledged
that
latter
are
responsible
portion
biomedical
effects.
The
dynamic
interplay
CAP-derived
ROS
other
components
contributes
unique
versatile
properties
enabling
it
interact
biological
systems
elicit
various
therapeutic
effects,
including
potential
While
shown
promise
types,
application
against
relatively
unexplored.
This
review
assesses
strategy
CSCs,
focusing
on
ability
regulate
cellular
states
achieve
redox
homeostasis.
done
by
providing
overview
CSC
characteristics
demonstrating
recent
findings
CAP’s
efficacy
these
cells.
By
insights
into
attributes
this
work
advanced
understanding
oncology
strategies.
Journal of Evidence-Based Integrative Medicine,
Journal Year:
2022,
Volume and Issue:
27
Published: Jan. 1, 2022
The
flavonoid
silymarin
extracted
from
the
seeds
of
Sylibum
marianum
is
a
mixture
6
flavolignan
isomers.
3
more
important
isomers
are
silybin
(or
silibinin),
silydianin,
and
silychristin.
Silybin
functionally
most
active
these
compounds.
This
group
flavonoids
has
been
extensively
studied
they
have
used
as
hepato-protective
substances
for
mushroom
Amanita
phalloides
intoxication
mainly
chronic
liver
diseases
such
alcoholic
cirrhosis
nonalcoholic
fatty
liver.
Hepatitis
C
progression
not,
or
slightly,
modified
by
silymarin.
Recently,
it
also
proposed
SARS
COVID-19
infection
therapy.
biochemical
molecular
mechanisms
action
in
cancer
subjects
ongoing
research.
Paradoxically,
many
its
identified
actions
antioxidant,
promoter
ribosomal
synthesis,
mitochondrial
membrane
stabilization,
may
seem
protumoral
at
first
sight,
however,
compounds
clear
anticancer
effects.
Some
them
are:
decreasing
migration
through
multiple
targeting,
hypoxia
inducible
factor-1α
expression,
inducing
apoptosis
some
malignant
cells,
inhibiting
promitotic
signaling
among
others.
Interestingly,
antitumoral
activity
limited
to
cells
while
nonmalignant
not
be
affected.
Furthermore,
there
long
history
use
human
without
toxicity
after
prolonged
administration.
ample
distribution
easy
accessibility
milk
thistle—the
source
compounds,
over
counter
availability,
fact
that
weed,
controversial
issues
regarding
bioavailability,
being
nutraceutical
rather
than
drug,
somehow
led
medical
professionals
view
effects
with
skepticism.
fundamental
reason
why
never
achieved
bedside
status
treatment.
However,
spite
all
effects,
actually
dual
cases
pancreatic
can
promote
stemness.
review
deals
recent
investigations
elucidate
this
cancer,
consider
possibility
repurposing
it.
Particular
attention
dedicated
silymarin's
role
controversies
real
effectiveness.
Redox Biology,
Journal Year:
2023,
Volume and Issue:
65, P. 102798 - 102798
Published: June 27, 2023
Despite
continuous
therapeutic
progress,
cancer
remains
an
often
fatal
disease.
In
the
early
2010s,
first
evidence
in
rodent
models
suggested
promising
antitumor
action
of
gas
plasma
technology.
Medical
is
a
partially
ionized
depositing
multiple
physico-chemical
effectors
onto
tissues,
especially
reactive
oxygen
and
nitrogen
species
(ROS/RNS).
Today,
evergrowing
body
experimental
suggests
multifaceted
roles
medical
plasma-derived
ROS/RNS
targeting
alone
or
combination
with
oncological
treatment
schemes
such
as
ionizing
radiation,
chemotherapy,
immunotherapy.
Intriguingly,
technology
was
recently
unraveled
to
have
immunological
dimension
by
inducing
immunogenic
cell
death,
which
could
ultimately
promote
existing
immunotherapies
via
situ
autologous
tumor
vaccine
schemes.
Together
clinical
reporting
beneficial
effects
patients
following
therapy,
it
time
summarize
main
concepts
along
chances
limitations
onco-therapy
from
biological,
immunological,
clinical,
technological
point
view.
Advanced Science,
Journal Year:
2020,
Volume and Issue:
7(10)
Published: March 30, 2020
Medical
technologies
from
physics
are
imperative
in
the
diagnosis
and
therapy
of
many
types
diseases.
In
2013,
a
novel
cold
physical
plasma
treatment
concept
was
accredited
for
clinical
therapy.
This
gas
jet
technology
generates
large
amounts
different
reactive
oxygen
nitrogen
species
(ROS).
Using
melanoma
model,
is
tested
as
anticancer
agent.
Plasma
derived
ROS
diminish
tumor
growth
vitro
vivo.
Varying
feed
mixture
modifies
composition
ROS.
Conditions
rich
atomic
correlate
with
killing
activity
elevate
intratumoral
immune-infiltrates
CD8
Frontiers in Cell and Developmental Biology,
Journal Year:
2022,
Volume and Issue:
10
Published: July 26, 2022
Cold
atmospheric
plasma
(CAP)
is
an
emerging
and
promising
oncotherapy
with
considerable
potential
advantages
that
traditional
treatment
modalities
lack.
The
objective
of
this
study
was
to
investigate
the
effect
mechanism
plasma-inhibited
proliferation
plasma-induced
apoptosis
on
human
lung
cancer
colon
cells
in
vitro
vivo
.
Piezobrush
®
PZ2,
a
handheld
CAP
unit
based
piezoelectric
direct
discharge
technology,
used
generate
deliver
non-thermal
plasma.
Firstly,
PZ2
inhibited
HT29
colorectal
A549
using
CCK8
assay,
caused
morphological
changes
at
cellular
subcellular
levels
transmission
electron
microscopy,
suppressed
both
types
tumor
cell
migration
invasion
Transwell
Matrigel
assay.
Secondly,
we
confirmed
AO/EB
staining
coupled
flow
cytometry,
verified
production
apoptosis-related
proteins,
such
as
cytochrome
c,
PARP,
cleaved
caspase-3
caspase-9,
Bcl-2
Bax,
western
blotting.
Finally,
aforementioned
results
were
tested
cell-derived
xenograft
mouse
models,
anticancer
attributed
CAP-mediated
apoptosis.
immunohistochemical
analysis
revealed
expression
caspase-3,
PARP
Bax
upregulated
whereas
downregulated
after
treatment.
These
findings
collectively
suggest
activation
mitochondrial
pathway
involved
during
-induced
Journal of Functional Foods,
Journal Year:
2023,
Volume and Issue:
104, P. 105502 - 105502
Published: March 21, 2023
Cancer
is
identified
as
second
leading
causes
of
death
and
imposes
a
significant
psychological
economic
burden
on
societies.
Due
to
its
high
prevalence,
main
cause
worldwide,
there
continuing
need
discover
new
potential
anticancer
compounds.
Plant-derived
compounds
have
recently
attracted
more
attention
among
researchers
for
their
potent
anti-cancer
properties.
A
numerous
research,
including
in-vitro,
in-vivo,
preclinical,
clinical,
epidemiological
studies,
has
indicated
that
the
flavonoid
silymarin
comprehensive
preventive
therapeutic
effects
array
inflammation-driven
diseases,
cancer.
Silymarin
clear
activities
through
distinctive
mechanisms
modulation
apoptosis
in-vitro
survival
in-vivo.
The
chemoprotection
constituent
suggest
they
could
be
promising
agents
in
various
cancer
types.
This
review
focus
vivo
vitro
variety
cancers,
explores
signaling
pathways
modulated
by
this
compound.
Journal of Biophotonics,
Journal Year:
2020,
Volume and Issue:
14(3)
Published: Nov. 24, 2020
Abstract
Cold
atmospheric
plasma
(CAP)
applications
can
potentially
lead
to
effective
therapy
for
numerous
skin
diseases.
Our
aim
is
systematically
review
the
available
data
and
map
use
of
CAP
in
dermatology.
PubMed,
Embase
Web
science
were
explored
before
2020
studies
regarding
A
total
166
finally
included.
74.1%
these
used
indirect
sources.
Most
jet
(67.5%).
Argon
was
mostly
working
gas
(48.2%).
Plasma
application
itself
could
be
direct
(89.2%)
(16.3%).
The
proportion
with
vivo
results
remained
57.2%,
which
most
concerned
treatment
(97.9%).
Analyses
performed
indicate
that
has
been
beneficial
many
disorders.
While,
focused
on
wound
healing
melanoma
treatment.
This
study
provides
a
brief
overview
sources
relative
medical
Oxidative Medicine and Cellular Longevity,
Journal Year:
2021,
Volume and Issue:
2021(1)
Published: Jan. 1, 2021
Despite
recent
advances
in
therapy,
cancer
still
is
a
devastating
and
life‐threatening
disease,
motivating
novel
research
lines
oncology.
Cold
physical
plasma,
partially
ionized
gas,
new
modality
research.
Physical
plasma
produces
various
physicochemical
factors,
primarily
reactive
oxygen
nitrogen
species
(ROS/RNS),
causing
cell
death
when
supplied
at
supraphysiological
concentrations.
This
review
outlines
the
biomedical
consequences
of
treatment
experimental
including
modalities.
It
also
summarizes
current
knowledge
on
intracellular
signaling
pathways
triggered
by
to
induce
death.
Besides
inactivation
tumor
cells,
an
equally
important
aspect
inflammatory
context
which
occurs
suppress
or
promote
responses
immune
cells.
mainly
governed
release
damage‐associated
molecular
patterns
(DAMPs)
provoke
immunogenic
(ICD)
that,
turn,
activates
cells
innate
system
adaptive
antitumor
immunity.
The
pivotal
role
treatment,
general,
highlighted
many
clinical
trials
success
stories
using
checkpoint
immunotherapy.
Hence,
potential
ICD
immunity
targeting
lesions
systemically
discussed.
Cancers,
Journal Year:
2021,
Volume and Issue:
13(12), P. 2889 - 2889
Published: June 9, 2021
Cold
atmospheric
plasma
(CAP)
has
emerged
as
a
highly
selective
anticancer
agent,
most
recently
in
the
form
of
plasma-activated
medium
(PAM).
Since
epithelial-mesenchymal
transition
(EMT)
been
implicated
resistance
to
various
cancer
therapies,
we
assessed
whether
EMT
status
is
associated
with
PAM
response.
Mesenchymal
breast
cell
lines,
well
mesenchymal
variant
an
isogenic
EMT/MET
human
system
(PMC42-ET/LA),
were
more
sensitive
treatment
than
their
epithelial
counterparts,
contrary
responses
other
therapies.
The
same
trend
was
seen
luminal
muscle-invasive
bladder
model
(TSU-Pr1/B1/B2)
and
non-muscle-invasive
basal
5637
line.
Three-dimensional
spheroid
cultures
lines
less
compared
two-dimensional
counterparts;
however,
incrementally
better
again
mesenchymally-shifted
lines.
This
study
provides
evidence
that
preferentially
inhibits
carcinoma
cells,
which
have
Thus,
may
represent
novel
can
selectively
inhibit
triple-negative
cancers
subset
aggressive
cancers,
tend
be
mesenchymal.
Our
approach
potentially
utilized
for
exhibiting
opens
new
opportunities
CAP
promising
onco-therapy.